Skip to content
Anna Ahlberg talks at DNB

Investor Relations

Leading Position in a Global Niche Market

Surgical Science is a medical simulation company – with core competence around its proprietary software and hardware for the simulation of instrument/tissue interactions. Based on its own technology, turnkey simulators are developed, manufactured, and sold to teaching hospitals, clinics, and medical training centers. More than 8,000 systems have been delivered worldwide supported by more than 400 validation studies. In parallel with its own products, Surgical Science also provides medical technology companies with device-specific simulation solutions.

Surgical Science has successfully over the years acquired simulation companies Simbionix, Mimic Technologies, and SenseGraphics, to form a world-leading simulation company. The company is listed on Nasdaq First North Growth Market in Stockholm, Sweden.

Overview of Surgical Science

CEO Gisli Hennermark and CFO Anna Ahlberg at our latest Capital Markets Day, 22 Feb 2023
Gisli Hennermark speaks at DNB

Financial Reports

This section lists all available financial information about Surgical Science Sweden AB, listed on Nasdaq First North Growth Market in Stockholm.

Press Release Subscription

Calendar

The Share

Surgical Science is listed on Nasdaq First North Growth Market since June 19, 2017.

 

Owner list

swipe to see all data

Owner Concentration

swipe to see all data

Country Distribution

swipe to see all data

Owner Holding Distribution

swipe to see all data

IR Contact

The Company’s Certified Adviser

Carnegie Investment Bank AB (publ)

Phone: +46 (0)73 856 42 65

E-mail: certifiedadviser@carnegie.se

Skip to navigation